Candesartan

Phase 4 承認済み Small molecule
Half-Life
9 hours
Bioavailability
Protein Binding
Molecular Weight
610.7 g/mol
LogP
4.1
Phase
4

An angiotensin II receptor blocker used to treat high blood pressure and heart failure. By blocking the angiotensin II receptor, it dilates blood vessels and reduces the workload on the heart. It is also used to protect kidney function in patients with type 2 diabetes and high blood pressure.

分子量

610.6640 g/mol

LogP

4.10

TPSA

119.00 Ų

リピンスキーの五則

適合

治療領域

薬物分類

作用機序

Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Pharmacokinetics (PK)

Half-Life 9 hours

Pharmacodynamics (PD)

機序

Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O

InChI

InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)

Molecular Formula

C33H34N6O6

HBD / HBA

2 / 7

回転可能結合数

7

重原子数

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

An angiotensin II receptor blocker used to treat high blood pressure and heart failure. By blocking the angiotensin II receptor, it dilates blood vessels and reduces the workload on the heart. It is also used to protect kidney function in patients with type 2 diabetes and high blood pressure.

Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Key pharmacokinetic parameters for Candesartan: Half-life: 9 hours.

Yes, Candesartan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • PubChem — National Center for Biotechnology Information (NCBI). CID 2541. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.